May 15, 2018 / 11:39 AM / in 6 days

BRIEF-Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing From Flying L Partners

May 15 (Reuters) - Imprimis Pharmaceuticals Inc:

* SURFACE PHARMACEUTICALS, INC. ANNOUNCES $20 MILLION SERIES A FINANCING FROM FLYING L PARTNERS

* IMPRIMIS PHARMACEUTICALS - SURFACE PHARMA INTENDS TO USE PROCEEDS OF FINANCING TO ADVANCE CLINICAL DEVELOPMENT PROGRAMS FOCUSED ON OCULAR SURFACE DISEASE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below